The clinicopathological significance of bcl-2 expression in the surgical treatment of laryngeal carcinoma
- 1 April 2001
- journal article
- review article
- Published by Wiley in Clinical Otolaryngology
- Vol. 26 (2) , 129-133
- https://doi.org/10.1046/j.1365-2273.2001.00441.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Enhanced apoptosis correlates with poor survival in patients with laryngeal cancer but not with cell proliferation, bcl-2 or p53 expressionEuropean Journal Of Cancer, 1999
- Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expressionCancer, 1999
- Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neckCancer, 1999
- Prognostic Significance of BCL-2 Expression in Localized Squamous Cell Carcinoma of the Head and NeckAnnals of Otology, Rhinology & Laryngology, 1997
- Analysis of bcl-2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia, and nasopharyngeal carcinoma: Association with p53 expressionHuman Pathology, 1997
- Correlation of Tumor Markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 With Survival and Metastasis in Laryngeal Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1996
- What is the value of bcl‐2 protein detection for histopathologists?Histopathology, 1995
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993